CAPTRUST Financial Advisors
STLNW

CAPTRUST Financial Advisors’s Starling Oncology, Inc. Warrant STLNW Stock Holding History

CAPTRUST Financial Advisors’s Portfolio STLNW Stock Details STLNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-3,957
Closed -$3K – 5132
2021
Q4 		$3K Hold
3,957
– – ﹤0.01% 4309
2021
Q3 		$5K Hold
3,957
– – ﹤0.01% 3962
2021
Q2 		$7K Sell
3,957
-192
-5% -$258 ﹤0.01% 3723
2021
Q1 		$6K Sell
4,149
-688
-14% -$1.28K ﹤0.01% 3676
2020
Q4 		$9K Buy
+4,837
New +$8.34K ﹤0.01% 2635

Other funds holding STLNW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
DCM
Difesa Capital Management New York $38.1M AUM 39.86% 1-Year Est. Return
USPCM
Union Square Park Capital Management New York $176M AUM 51.52% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

CAPTRUST Financial Advisors's STLNW Position: Q1 2022 in Review

CAPTRUST Financial Advisors sold out of Starling Oncology, Inc. Warrant (STLNW) in Q1 2022, closing a stake of 3,957 shares — an estimated $3K sold.

CAPTRUST Financial Advisors first reported a position in STLNW in Q4 2020 and held it in 5 quarters. The position peaked at $9K in Q4 2020. 12 funds tracked by Wall St. Rank hold STLNW as of Q1 2022.

  • CAPTRUST Financial Advisors reported no remaining Starling Oncology, Inc. Warrant position as of Q1 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 3,957 Starling Oncology, Inc. Warrant shares in Q1 2022, an estimated $3K.
  • CAPTRUST Financial Advisors first reported a position in Starling Oncology, Inc. Warrant in Q4 2020 and held it in 5 quarters.
  • CAPTRUST Financial Advisors's Starling Oncology, Inc. Warrant position peaked at $9K in Q4 2020.
  • 12 funds tracked by Wall St. Rank held Starling Oncology, Inc. Warrant as of Q1 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q1 2022, filed 16 May 2022.